What is Sitaxentan?

Sitaxentan sodium (TBC-11251) is a medication for the treatment of pulmonary arterial hypertension (PAH). It was marketed as Thelin by Encysive Pharmaceuticals until Pfizer purchased Encysive in February 2008. In 2010, Pfizer voluntarily removed sitaxentan from the market due to concerns about liver toxicity.

Questions and answers on "Sitaxentan"

Hi sir, I am Female of 23 years i am suffering from chest pain the following echocardiography report as follows. MILD DILATION OF RA/RV GROSSLY...

doctor1 MD

As per the details u have mentioned u were having primary PAH. I.e pulmonary her tension with out any valvular or anatomical problems,...

Read Full Thread   Ask a Doctor Now

Recent questions on Sitaxentan

Ask Question
Doctor Image

Hi, I am Dr. Andrew Rynne (Family Physician). I will be guiding you through the process. Please write your question below.

Related Disease & Conditions
Related Drugs/Medications
Related Medical Topics